• β-Elemene: Applied Workflows in Adipogenesis and Neuroprotec

  2026-06-21

  β-Elemene stands out as a versatile tool for both metabolic and neuroprotection research, offering reproducible modulation of key signaling pathways. Discover evidence-backed workflows and troubleshooting strategies that maximize assay robustness and translational insight.

• Cell Counting Kit-8 (CCK-8) Plus: Technical Guide and Protoc

  2026-06-20

  Cell Counting Kit-8 (CCK-8) Plus enables rapid, sensitive measurement of cell viability, proliferation, and cytotoxicity using a WST-8 tetrazolium salt assay. This product is best suited for quantitative cell-based assays in drug screening, cytotoxicity analysis, and proliferation workflows where high sensitivity and reproducibility are required. It is not appropriate for cell-free systems or endpoints lacking dehydrogenase activity.

• Applied ROS Detection: 2',7'-Dichlorofluorescein Diacetate P

  2026-06-19

  Harnessing the 2',7'-Dichlorofluorescein diacetate probe unlocks precise, real-time detection of intracellular oxidative stress in complex cancer models. This guide distills advanced experimental workflows, troubleshooting insights, and innovations from leading nanocarrier-enabled chemotherapy studies—empowering reproducible, high-impact redox assays.

• 5-hme-dCTP: Precision Epigenetic Mapping for Plant Stress Re

  2026-06-19

  5-hme-dCTP empowers researchers to dissect DNA hydroxymethylation with single-base resolution, unlocking insights into plant gene regulation under drought stress. This guide outlines advanced workflows, troubleshooting strategies, and actionable innovations inspired by the latest high-resolution rice genomics.

• AIBP-LRP2 Axis Restricts CXCR4+ Capillary Expansion in Ische

  2026-06-18

  This study uncovers how AIBP-LRP2–mediated HDL uptake constrains the expansion of CXCR4+ stemlike capillary endothelial cells, limiting collateral circulation in ischemic tissues. By dissecting the interplay between lipid metabolism and vascular remodeling, the findings open new avenues for targeted revascularization therapies in peripheral artery disease.

• Necrostatin 2 (Nec-2): Applied Workflows in Necroptosis Rese

  2026-06-18

  Necrostatin 2 (Nec-2) is a potent RIPK2 inhibitor revolutionizing necroptosis inhibition, especially in apoptosis-resistant and ischemic stroke models. This article delivers detailed workflow guidance, troubleshooting strategies, and insights drawn from cutting-edge membrane biology to maximize assay reliability and translational impact.

• EZ Cap™ Human PTEN mRNA (ψUTP): Redefining mRNA Stability an

  2026-06-17

  Discover how EZ Cap™ Human PTEN mRNA (ψUTP), a next-generation in vitro transcribed mRNA, offers unprecedented stability and tumor suppressor restoration for advanced cancer research. This analysis explores the scientific innovations behind its design and practical assay implications, setting it apart from previous applications.

• Central PVN AT1aR Deficiency Mitigates Renal Fibrosis via Sy

  2026-06-17

  Wan et al. (2024) demonstrate that deficiency of angiotensin II type 1a receptors (AT1aR) within the hypothalamic paraventricular nucleus (PVN) attenuates renal fibrosis in a mouse model of folic acid-induced chronic kidney disease by reducing sympathetic nerve discharge. Their findings clarify the central neural mechanisms linking the brain renin-angiotensin system to kidney fibrosis, highlighting the PVN-RVLM pathway as a potential therapeutic target.

• Technical Guidance for Using Angiotensin I/II (1-5) in RAS R

  2026-06-16

  Angiotensin I/II (1-5) (Asp-Arg-Val-Tyr-Ile) is a defined peptide fragment for precise modeling of the renin-angiotensin system in blood pressure and aldosterone signaling studies. It is intended for cardiovascular and renal research workflows where mechanistic control and reproducibility are required. Use is not recommended for unrelated peptide signaling or exploratory off-target assays.

• Stattic: Precision STAT3 Inhibition for Lymphangiogenesis Re

  2026-06-16

  Explore how Stattic, a potent STAT3 inhibitor, enables advanced study of lymphangiogenesis and cancer biology. This article uniquely connects STAT3 pathway inhibition to emerging findings in cadmium-induced lymphatic remodeling, providing unmatched experimental guidance.

• IWR-1-endo: Advanced Insights into Wnt Pathway Modulation

  2026-06-15

  Explore how IWR-1-endo, a potent Wnt signaling inhibitor, enables new frontiers in pathway-targeted research. This article reveals mechanistic depth and practical guidance for leveraging IWR-1-endo in advanced assay design, setting it apart from prior overviews.

• Short-Scale Break-Induced Replication in Mouse Oocytes: New

  2026-06-15

  This study uncovers how DNA double-strand breaks (DSBs) induce short-scale break-induced replication (ssBIR) and amplify damage in fully grown mouse oocytes. The findings refine our understanding of DNA repair pathway choice and highlight the use of DNA synthesis inhibitors, such as ddATP, as informative mechanistic probes.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-14

  This study provides a detailed molecular and epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong Province. The findings highlight the predominance and horizontal transferability of blaNDM-1 on plasmids, elucidate resistance patterns, and map the genotypic and clinical distribution of CEGs, informing antimicrobial resistance research and infection control strategies.

• Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP): Workflow Advanc

  2026-06-13

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) from APExBIO delivers unmatched stability, immune evasion, and bioluminescent sensitivity for gene expression, cell viability, and in vivo imaging workflows. This guide unpacks experimental advantages, protocol optimizations, and troubleshooting strategies that set this advanced reporter apart for robust, reproducible research.

• ETS1 Regulates Sumoylation-Dependent Mitophagy in BPD Models

  2026-06-12

  This study uncovers how ETS1 protects against bronchopulmonary dysplasia (BPD) by targeting the SENP2/HSPA8/FUNDC1 axis and suppressing mitochondrial damage-induced autophagy. The findings clarify a key sumoylation-dependent pathway in mitophagy regulation, offering new molecular targets for neonatal lung disease intervention.

407 records 11/28 page Previous Next First page 上5页 1112131415 下5页 Last page